Rhodia Strategically Positions Its Pharma Ingredients Business.(Brief Article)(Statistical Data Included)

Chemical Market Reporter, April, 2000 by MIRASOL, FELIZA

Rhodia is repositioning its pharmaceutical ingredients business as part of its strategy to expand its leading position in key markets. A major part of that strategy is to reinforce its status as a high-security, low-risk global supplier of pharmaceutical ingredients.

"Rhodia's position in pharmaceutical ingredients is aligned with an important part of the company's strategy to focus on products and markets in which it is a leader," says Marc-Antoine Mallet, president of Rhodia's global pharmaceutical ingredients business.

Rhodia is the world's largest manufacturer of aspirin (acetylsalicylic acid), salicylic acid and its derivatives, and calcium phosphates, as well as the second largest producer of acetaminophen. It is also among the leaders in...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here